Adrenalectomy Completely Cured Hypertension in Patients With Familial Hyperaldosteronism Type I Who Had Somatic KCNJ5 Mutation

J Clin Endocrinol Metab. 2019 Nov 1;104(11):5462-5466. doi: 10.1210/jc.2019-00689.

Abstract

Context: Familial hyperaldosteronism type I (FH-I) or glucocorticoid-remediable aldosteronism (GRA) is caused by unequal crossing over of the steroid 11β-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) genes. Somatic KCNJ5 mutations have not been reported in patients with GRA; therefore, the appropriate treatment and prognosis of such concurrent cases remain unknown.

Case description: Two siblings of a Taiwanese family with GRA were found to have adrenal adenomas and somatic KCNJ5 mutations. Complete clinical cure was achieved after unilateral adrenalectomy. Furthermore, the conversion site of the chimeric gene was identified by direct sequencing.

Conclusions: We report the coexistence of a somatic KCNJ5 mutation and GRA. Patients with GRA whose blood pressure management develops resistance to glucocorticoid treatment could therefore benefit from a lateralization test. The promising outcomes after unilateral adrenalectomy presented in this report offer new perspectives for further research into various PA subtypes.

Publication types

  • Case Reports

MeSH terms

  • Adrenalectomy*
  • Aged
  • G Protein-Coupled Inwardly-Rectifying Potassium Channels / genetics*
  • Humans
  • Hyperaldosteronism / genetics
  • Hyperaldosteronism / surgery*
  • Hypertension / genetics
  • Hypertension / surgery*
  • Male
  • Middle Aged
  • Mutation
  • Siblings
  • Taiwan
  • Treatment Outcome

Substances

  • G Protein-Coupled Inwardly-Rectifying Potassium Channels
  • KCNJ5 protein, human

Supplementary concepts

  • Glucocorticoid-Remediable Aldosteronism